Changes in Gait Speed During a 12-Month Multidisciplinary Obesity Management Program Including Semaglutide: A Real-World Observational Study in Japanese Adults With Musculoskeletal Disorders.

A real-world observational study examined how gait speed changed over 12 months in Japanese adults with musculoskeletal disorders who participated in a multidisciplinary obesity management program incorporating semaglutide. The findings offer insight into how GLP-1 receptor agonist-based weight management may influence a functional mobility measure highly relevant to physical therapy practice. Gait speed is a recognized clinical outcome for assessing physical function, making this study pertinent to PTs managing patients with obesity-related musculoskeletal conditions.

Read full article at PubMed / Intern Med ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by PubMed / Intern Med at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.